The Efficacy and Safety of Efsubaglutide Alfa in Overweight/Obesity（SPARKLE）

Clinical trial NCT07114419 · RECRUITING

Trial details

NCT number: NCT07114419
Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Obesity and Overweight

Start date: 2025-08-25
Primary completion: 2026-06-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.